|
1
|
Bedogni B, Warneke JA, Nickoloff BJ,
Giaccia AJ and Powell MB: Notch1 is an effector of Akt and hypoxia
in melanoma development. J Clin Invest. 118:3660–3670. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sinnberg T, Lasithiotakis K, Niessner H,
Schittek B, Flaherty KT, Kulms D, Maczey E, Campos M, Gogel J,
Garbe C, et al: Inhibition of PI3K-AKT-mTOR signaling sensitizes
melanoma cells to cisplatin and temozolomide. J Invest Dermatol.
129:1500–1515. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu Z, Fan H, Lv G, Zhou Q, Yang B, Zheng J
and Cao W: 5-Aminolevulinic acid-mediated sonodynamic therapy
induces anti-tumor effects in malignant melanoma via
p53-miR-34a-Sirt1 axis. J Dermatol Sci. 79:155–162. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin K, Baritaki S, Militello L, Malaponte
G, Bevelacqua Y and Bonavida B: The role of B-RAF mutations in
melanoma and the induction of EMT via dysregulation of the
NF-κB/Snail/RKIP/PTEN circuit. Genes Cancer. 1:409–420. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siddique HR and Saleem M: Role of BMI1, a
stem cell factor, in cancer recurrence and chemoresistance:
Preclinical and clinical evidences. Stem Cells. 30:372–378. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu F, Garcia AM Gomez and Meyskens FL Jr:
NADPH oxidase 1 overexpression enhances invasion via matrix
metalloproteinase-2 and epithelial-mesenchymal transition in
melanoma cells. J Invest Dermatol. 132:2033–2041. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu
LJ, Kong QL, Xu LH, Zhang X, Liu WL, et al: The polycomb group
protein Bmi-1 represses the tumor suppressor PTEN and induces
epithelial-mesenchymal transition in human nasopharyngeal
epithelial cells. J Clin Invest. 119:3626–3636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ota I, Masui T, Kurihara M, Yook JI,
Mikami S, Kimura T, Shimada K, Konishi N, Yane K, Yamanaka T, et
al: Snail-induced EMT promotes cancer stem cell-like properties in
head and neck cancer cells. Oncol Rep. 35:261–266. 2016.PubMed/NCBI
|
|
10
|
Guo BH, Feng Y, Zhang R, Xu LH, Li MZ,
Kung HF, Song LB and Zeng MS: Bmi-1 promotes invasion and
metastasis, and its elevated expression is correlated with an
advanced stage of breast cancer. Mol Cancer. 10:102011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song LB, Zeng MS, Liao WT, Zhang L, Mo HY,
Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, et al: Bmi-1 is a novel
molecular marker of nasopharyngeal carcinoma progression and
immortalizes primary human nasopharyngeal epithelial cells. Cancer
Res. 66:6225–6232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu X, Liu Y, Su J, Li D, Hu J, Huang Q, Lu
M, Liu X, Ren J, Chen W, et al: Downregulation of Bmi-1 is
associated with suppressed tumorigenesis and induced apoptosis in
CD44+ nasopharyngeal carcinoma cancer stem-like cells.
Oncol Rep. 35:923–931. 2016.PubMed/NCBI
|
|
13
|
Mihic-Probst D, Kuster A, Kilgus S,
Bode-Lesniewska B, Ingold-Heppner B, Leung C, Storz M, Seifert B,
Marino S, Schraml P, et al: Consistent expression of the stem cell
renewal factor BMI-1 in primary and metastatic melanoma. Int J
Cancer. 121:1764–1770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Tetzlaff MT, Cui R and Xu X:
miR-200c inhibits melanoma progression and drug resistance through
down-regulation of BMI-1. Am J Pathol. 181:1823–1835. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Madonna G, Ullman CD, Gentilcore G,
Palmieri G and Ascierto PA: NF-κB as potential target in the
treatment of melanoma. J Transl Med. 10:532012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia D, Srinivas H, Ahn YH, Sethi G, Sheng
X, Yung WK, Xia Q, Chiao PJ, Kim H, Brown PH, et al:
Mitogen-activated protein kinase kinase-4 promotes cell survival by
decreasing PTEN expression through an NF kappa B-dependent pathway.
J Biol Chem. 282:3507–3519. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gheorgheosu D, Jung M, Ören B, Schmid T,
Dehelean C, Muntean D and Brüne B: Betulinic acid suppresses
NGAL-induced epithelial-to-mesenchymal transition in melanoma. Biol
Chem. 394:773–781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ronca R, Di Salle E, Giacomini A, Leali D,
Alessi P, Coltrini D, Ravelli C, Matarazzo S, Ribatti D, Vermi W,
et al: Long pentraxin-3 inhibits epithelial-mesenchymal transition
in melanoma cells. Mol Cancer Ther. 12:2760–2771. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie G, Ji A, Yuan Q, Jin Z, Yuan Y, Ren C,
Guo Z, Yao Q, Yang K, Lin X, et al: Tumour-initiating capacity is
independent of epithelial-mesenchymal transition status in breast
cancer cell lines. Br J Cancer. 110:2514–2523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Geng S, Guo Y, Wang Q, Li L and Wang J:
Cancer stem-like cells enriched with CD29 and CD44 markers exhibit
molecular characteristics with epithelial-mesenchymal transition in
squamous cell carcinoma. Arch Dermatol Res. 305:35–47. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiao B, Chen Z, Hu F, Tao Q and Lam AK:
BMI-1 activation is crucial in hTERT-induced epithelial-mesenchymal
transition of oral epithelial cells. Exp Mol Pathol. 95:57–61.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang
Z, Yang CJ, Yuan L and Ouyang G: Twist2 contributes to breast
cancer progression by promoting an epithelial-mesenchymal
transition and cancer stem-like cell self-renewal. Oncogene.
30:4707–4720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY,
Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ansieau S, Bastid J, Doreau A, Morel AP,
Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S,
et al: Induction of EMT by twist proteins as a collateral effect of
tumor-promoting inactivation of premature senescence. Cancer Cell.
14:79–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang L, Wu J, Yang Y, Liu L, Song L, Li J
and Li M: Bmi-1 promotes the aggressiveness of glioma via
activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer.
12:4062012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hao L, Ha JR, Kuzel P, Garcia E and Persad
S: Cadherin switch from E- to N-cadherin in melanoma progression is
regulated by the PI3K/PTEN pathway through Twist and Snail. Br J
Dermatol. 166:1184–1197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Felx M, Guyot MC, Isler M, Turcotte RE,
Doyon J, Khatib AM, Leclerc S, Moreau A and Moldovan F:
Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving
the transcription factor NF-kappaB in human osteosarcoma. Clin Sci.
110:645–654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesenchymal transition in mammary epithelial cells is
mediated by NF-kB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Radisky DC, Levy DD, Littlepage LE, Liu H,
Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et
al: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and
genomic instability. Nature. 436:123–127. 2005. View Article : Google Scholar : PubMed/NCBI
|
